肝细胞癌相关的核编码线粒体基因及临床信息的综合预后模型
克德尔亚·艾山江, 傅怡, 赖冬林, 邬海龙, 龚伟

An integrated prognostic model of nuclear-encoded mitochondrial gene signature and clinical information for hepatocellular carcinoma
Aishanjiang Kedeerya, FU Yi, LAI Donglin, WU Hailong, GONG Wei
表3 临床队列中HCC患者的临床病理特征
Tab 3 Clinicopathological features of HCC patients in the clinical cohort
FeatureTotal/n(%)
Age
≤50 year8 (23.53)
>50 year26 (76.47)
Gender
Male24 (70.59)
Female10 (29.41)
TNM stage
Ⅰ15 (44.12)
Ⅱ5 (14.71)
Ⅲ11 (32.35)
Ⅳ3 (8.82)
AFP
≤20 ng·mL-121 (61.76)
>20 ng·mL-113 (38.24)
Size
≤5 cm20 (58.82)
>5 cm14 (41.18)
Tumor number
=122 (64.71)
>112 (35.29)
HBsAg
-7 (20.59)
+27 (79.41)
GPT
≤40 U·L-125 (73.53)
>40 U·L-19 (26.47)
Cirrhosis
-16 (40.06)
+18 (59.94)